Cite
HARVARD Citation
Bender, O. et al. (2023). Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation. Archiv der Pharmazie. 356 (2), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bender, O. et al. (2023). Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation. Archiv der Pharmazie. 356 (2), p. n/a. [Online].